|Title:||Composition for contraception|
|Abstract:||A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17.beta.-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from .[.0.25 to 0.30.]. .Iadd.2.5 to 3.0 .Iaddend.mg of drospirenone and .[.0.1 to 0.2.]. .Iadd.1 to 2 .Iaddend.mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.|
|Inventor(s):||Spona; Jurgen (Vienna, AT), Dusterberg; Bernd (Berlin, DE), Ludicke; Frank (Geneva, CH)|
|Assignee:||Schering Aktiengesellschaft (Berlin, DE)|
Patent Claim Types:|
see list of patent claims
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
drospirenone; ethinyl estradiol; levomefolate calcium
|TABLET;ORAL||022532||Sep 24, 2010||RX||No||RE38253||<disabled>||Y|
drospirenone; ethinyl estradiol
|TABLET;ORAL||021676||Mar 16, 2006||RX||Yes||RE38253||<disabled>||Y|
|This preview shows a limited data set|
Subscribe for full access , or try a free trial
Export unavailable in trial.
Subscribe for complete access.
|Reinstatement due to payment of a late maintenance fee|
|Patent Number:||RE38253||Application Number:||10/080,617||Issue Date:||Sep 16 2003||Filing Date:||Feb 25 2002||Granted Date:||Jan 03 2008|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Germany||43 44 462||Dec 22, 1993|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.